Why the study?
How do pulmonary blood pressure and flow alterations affect plasma endothelin-1 production in young patients with congenital heart disease?
How do pulmonary blood pressure and flow alterations affect plasma endothelin-1 production in young patients with congenital heart disease?
Endothelin-1 production is increased by pulmonary pressure overload and congestion but decreased by volume overload in young patients with congenital heart disease.
Answers are grounded in this paper and cite their sources.
ET-1 levels associate with pressure overload but not volume overload in pediatric CHD; hypothesis-generating for biomarker utility, should not yet change practice.
To investigate the regulation of endothelin-1 (ET-1) production, cardiac catheterization was performed in young patients with congenital heart disease (27 +/- 5 months old, mean +/- SEM), and plasma levels of ET-1 in the inferior vena cava were measured by a sandwich-enzyme immunoassay. Plasma ET-1 levels of age-matched healthy controls were 1.55 +/- 0.07 pg/ml (n = 6). In patients with atrial septal defect [without pulmonary hypertension (PH)] who had volume but not pressure overload to the pulmonary circulation (PC), plasma ET-1 levels were significantly lower than in controls. In patients with PH due to ventricular septal defect (VSD) who had both volume and pressure overload to PC, the levels were significantly higher than in controls. In patients with PH and severe pulmonary congestion due to pulmonary venous stenosis (PVS), plasma ET-1 levels were significantly higher than in those with VSD, suggesting that ET-1 production is also augmented by pulmonary congestion. The present findings suggest that ET-1 production is increased by pressure overload to PC but decreased by volume overload to PC.
No takes yet. Share an insight, caveat, or question.
Ishikawa et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: